Bencycloquidium bromide

• Description :

  Bencycloquidium bromide, a muscarinic M (3) receptor antagonist, is an anticholinergic compound that acts as an anticholinergic bronchodilator. Bencycloquidium bromide can be used in the study for rhinitis[1][2].

• UNSPSC :

  12352005

• Target :

  MAChR

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Cancer; Inflammation/Immunology; Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/bencycloquidium-bromide.html

• Solubility :

  10 mM in DMSO

• Smiles :

  C[N+]1(CC2)CCC2C(C1)OCC(C3CCCC3)(C4=CC=CC=C4)O.[Br-]

• Molecular Formula :

  C21H32BrNO2

• Molecular Weight :

  410.39

• References & Citations :

  [1]Qin Xu, et al. Determination of bencycloquidium bromide in rat plasma by liquid chromatography-electrospray ionization-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 1;846 (1-2) :209-14.|[2]Jun-Xia Jiang, et al. Characterization of bencycloquidium bromide, a novel muscarinic M (3) receptor antagonist in guinea pig airways. Eur J Pharmacol. 2011 Mar 25;655 (1-3) :74-82.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched

• CAS Number :

  [860804-18-8]